Related Experiment Videos
Benzodiazepine sensitivity testing in the management of intractable seizure disorders in childhood
Insights
Benzodiazepine sensitivity testing aids in managing pediatric intractable seizures. A positive test predicts better outcomes with long-term benzodiazepine treatment for childhood epilepsy.
Area of Science:
- Pediatric Neurology
- Clinical Neurophysiology
- Pharmacology
Background:
- Intractable seizure disorders in children present significant management challenges.
- Benzodiazepines are a common treatment, but predicting response can be difficult.
- Electroencephalogram (EEG) abnormalities are frequent in pediatric epilepsy.
Purpose of the Study:
- To evaluate the utility of intravenous diazepam sensitivity testing in predicting long-term benzodiazepine treatment response in children with intractable seizures.
- To correlate EEG changes following diazepam administration with clinical outcomes.
Main Methods:
- A prospective study involving 40 children with intractable seizure disorders.
- Intravenous diazepam (0.2 mg/kg) was administered, and its effect on EEG epileptiform activity was monitored.
- Patients were subsequently treated with oral benzodiazepines, and clinical improvement was assessed.
Main Results:
- Diazepam abolished epileptiform activity in 21 cases (52.5%).
- A positive sensitivity test predicted a 76% clinical improvement rate with long-term benzodiazepine therapy.
- A negative sensitivity test was associated with a 64% non-improvement rate.
Conclusions:
- Benzodiazepine sensitivity testing is a valuable tool for guiding long-term management of intractable seizures in children.
- The test helps identify patients likely to benefit from benzodiazepine treatment, despite response variability.
- EEG response to acute diazepam challenge offers prognostic information for childhood epilepsy management.
Abstract:
The use of benzodiazepine sensitivity testing in the management of 40 children with intractable seizure disorders was studied. The aetiology and clinical syndromes varied widely with myoclonic, atonic and complex absence seizures predominating. Twenty-five cases had mixed seizure disorders. There was, likewise, a wide range of EEG abnormalities. Seven cases were in non-convulsive status at the time of testing. Diazepam (0.2 mg/kg) was given slowly intravenously and its effect on the EEG was observed. In 21 cases epileptiform activity was abolished. No change was seen in 13 cases and an unusual result was seen in 3. There was a paradoxical response in 3 cases, two of these associated with clinical seizures. Only 1 child in non-convulsive status had a positive result. Following testing, 32 patients went on to long-term oral benzodiazepine treatment. Twenty-one of these patients showed subsequent clinical improvement and 16/21 (76%) had had a positive sensitivity test previously. Eleven of these patients did not improve on long-term treatment. Seven out of the 11 (64%) had had a negative sensitivity test. These results suggest that the benzodiazepine sensitivity test is of value in the long-term management of intractable seizure disorders in childhood, but also emphasise the variability and unpredictability of response to benzodiazepine treatment.